Bain Capital Purchases Emcure Pharmaceuticals

December 24, 2013 Marcus Black Hedge Fund News

Bain Capital, the global investment firm founded and formerly run by presidential hopeful Mitt Romney, and valued at $70 billion, is buying Blackstone’s equity stake in Emcure Pharmaceuticals. Emcure is ranked as the 14th largest drug company in India by market share based on domestic sales.

“Blackstone has been a valuable strategic partner for us over the last few years,” said Satish Mehta, Emcure’s Managing Director and Chief Executive Officer. “In addition to providing growth capital to expand our business multi-fold, they also shared strategic insights to manage our fast growing business effectively. We are delighted that we have lived up to the faith reposed in us by Blackstone. We are also delighted to welcome a prestigious firm like Bain Capital and look forward to reaching greater heights in partnership with them.”

Bain Capital, Blackstone, Emcure Pharmaceuticals,

Comments are currently closed.